Extensive and growing evidence continues to reinforce fezolinetant as an effective treatment for moderate to severe VMS associated with menopause Preliminary analysis from OPTION-VMS observational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback